CEACAM5 antibody-drug conjugate formulations

The present invention provides stable formulations of human carcino-embryonic antigen related cell adhesion molecule 5 (hCEACAM5)-targeted antibody-drug conjugate huMAb2-3-SPDB-DM4, as well as methods of making and using the same. 本发明提供人类癌胚抗原相关细胞黏附分子5(hCEACAM5)-标靶抗体-药物缀合物huMAb2-3-SPDB-DM4的稳定制剂,及其制备和...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MANAHE-ALBERICI LINA, LEMAN, MARK, BEN-SHAID FAISAL, BERNSTBY ANDREAS, AUSSELIN JEAN-RENE, WHEELER SAMUEL
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention provides stable formulations of human carcino-embryonic antigen related cell adhesion molecule 5 (hCEACAM5)-targeted antibody-drug conjugate huMAb2-3-SPDB-DM4, as well as methods of making and using the same. 本发明提供人类癌胚抗原相关细胞黏附分子5(hCEACAM5)-标靶抗体-药物缀合物huMAb2-3-SPDB-DM4的稳定制剂,及其制备和使用方法。